Approval · Notice of Compliance 18131 · 2016
RECOTHROM: Notice of Compliance 18131
Issued May 26, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18131
- Date
- May 26, 2016
- Company
- Mallinckrodt Canada UlcPointe Claire, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of din ownership
Products in this notice
Medicinal ingredients
- THROMBIN ALFA 6,000 UNIT per VIAL
- THROMBIN ALFA 24,000 UNIT per VIAL